Xichen Lin's most recent trade in Structure Therapeutics Inc - ADR was a trade of 17,817 Ordinary Shares done at an average price of $0.3 . Disclosure was reported to the exchange on Sept. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 01 Sep 2026 | 17,817 | 246,777 | - | 0.3 | 6,058 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 17,817 | 125,081 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 01 Sep 2026 | 17,817 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 01 Sep 2026 | 5,939 | 5,939 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Sep 2026 | 4,539 | 100 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Sep 2026 | 1,300 | 4,639 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Sep 2026 | 100 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 18 Aug 2026 | 11,817 | 240,777 | - | 0.3 | 4,018 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2026 | 11,817 | 142,898 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 18 Aug 2026 | 11,817 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 18 Aug 2026 | 3,939 | 3,939 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Aug 2026 | 3,020 | 919 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Aug 2026 | 519 | 400 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Aug 2026 | 400 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 04 Aug 2026 | 11,817 | 240,777 | - | 0.3 | 4,018 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2026 | 11,817 | 154,715 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 04 Aug 2026 | 11,817 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 04 Aug 2026 | 3,939 | 3,939 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Aug 2026 | 3,100 | 839 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Aug 2026 | 839 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 14 Jul 2026 | 23,634 | 252,594 | - | 0.3 | 8,036 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 23,634 | 166,532 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 14 Jul 2026 | 23,634 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 14 Jul 2026 | 7,878 | 7,878 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2026 | 6,278 | 1,600 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2026 | 1,600 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 25 Jun 2026 | 23,634 | 252,594 | - | 0.3 | 8,036 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 23,634 | 190,166 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 25 Jun 2026 | 23,634 | 228,960 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jun 2026 | 7,878 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 25 Jun 2026 | 7,878 | 7,878 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 53,703 | 53,703 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 43,368 | 228,960 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 03 Mar 2026 | 18,735 | 185,592 | - | 21.0 | 393,248 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 01 Jul 2025 | 12,846 | 204,327 | - | 6.8 | 87,823 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 196,386 | 196,386 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 80,829 | 166,536 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 57,078 | 217,173 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 01 Mar 2025 | 6,441 | 160,095 | - | 7.9 | 50,991 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 03 Jun 2024 | 106,200 | 191,907 | - | 0.3 | 36,108 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 03 Jun 2024 | 106,200 | 85,707 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 106,200 | 213,800 | - | - | Share Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 03 Jun 2024 | 35,400 | 35,400 | - | - | American Depositary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Jun 2024 | 17,700 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Jun 2024 | 17,700 | 17,700 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 213,486 | 213,486 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 213,486 | 213,486 | - | - | Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 85,707 | 85,707 | - | 0 | Ordinary Shares |